SEMA4 HOLDINGS CORP (SMFR)
US81663L1017 - Common Stock
SMFR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 118 industry peers in the Health Care Providers & Services industry. SMFR has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, SMFR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SMFR has reported negative net income.
SMFR had a negative operating cash flow in the past year.
1.2 Ratios
SMFR has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for SMFR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SMFR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SMFR has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, SMFR has an improved debt to assets ratio.
2.2 Solvency
SMFR has an Altman-Z score of -2.45. This is a bad value and indicates that SMFR is not financially healthy and even has some risk of bankruptcy.
SMFR's Altman-Z score of -2.45 is on the low side compared to the rest of the industry. SMFR is outperformed by 80.00% of its industry peers.
SMFR has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
SMFR has a Debt to Equity ratio of 0.10. This is in the better half of the industry: SMFR outperforms 78.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.45 |
ROIC/WACCN/A
WACC8.77%
2.3 Liquidity
A Current Ratio of 1.89 indicates that SMFR should not have too much problems paying its short term obligations.
SMFR's Current ratio of 1.89 is fine compared to the rest of the industry. SMFR outperforms 73.91% of its industry peers.
A Quick Ratio of 1.62 indicates that SMFR should not have too much problems paying its short term obligations.
The Quick ratio of SMFR (1.62) is better than 68.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
SMFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.61%, which is quite impressive.
The Revenue has been growing slightly by 5.79% in the past year.
Measured over the past years, SMFR shows a quite strong growth in Revenue. The Revenue has been growing by 16.75% on average per year.
EPS 1Y (TTM)32.61%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q53.49%
Revenue 1Y (TTM)5.79%
Revenue growth 3Y16.75%
Revenue growth 5YN/A
Revenue growth Q2Q92.77%
3.2 Future
The Earnings Per Share is expected to grow by 8.27% on average over the next years. This is quite good.
The Revenue is expected to grow by 22.80% on average over the next years. This is a very strong growth
EPS Next Y14.52%
EPS Next 2Y26.72%
EPS Next 3Y20.59%
EPS Next 5Y8.27%
Revenue Next Year19.89%
Revenue Next 2Y3.4%
Revenue Next 3Y7.95%
Revenue Next 5Y22.8%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
SMFR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SMFR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as SMFR's earnings are expected to grow with 20.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.72%
EPS Next 3Y20.59%
5. Dividend
5.1 Amount
No dividends for SMFR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SEMA4 HOLDINGS CORP
NASDAQ:SMFR (1/9/2023, 7:00:03 PM)
After market: 0.32 +0.01 (+3.03%)0.3106
+0.07 (+26.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap118.47M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)32.61%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y14.52%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.79%
Revenue growth 3Y16.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y